Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) Equity Average: 2009-2025

Historic Equity Average for Prestige Consumer Healthcare (PBH) over the last 17 years, with Sep 2025 value amounting to $1.8 billion.

  • Prestige Consumer Healthcare's Equity Average rose 7.85% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year increase of 7.85%. This contributed to the annual value of $1.7 billion for FY2025, which is 12.50% up from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Equity Average stood at $1.8 billion for Q3 2025, which was down 0.27% from $1.8 billion recorded in Q2 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's Equity Average peaked at $1.8 billion during Q2 2025, and registered a low of $1.3 billion during Q1 2021.
  • Over the past 3 years, Prestige Consumer Healthcare's median Equity Average value was $1.7 billion (recorded in 2024), while the average stood at $1.7 billion.
  • In the last 5 years, Prestige Consumer Healthcare's Equity Average increased by 15.70% in 2021 and then decreased by 7.43% in 2023.
  • Prestige Consumer Healthcare's Equity Average (Quarterly) stood at $1.5 billion in 2021, then climbed by 10.96% to $1.7 billion in 2022, then fell by 5.15% to $1.6 billion in 2023, then grew by 12.23% to $1.8 billion in 2024, then grew by 7.85% to $1.8 billion in 2025.
  • Its Equity Average stands at $1.8 billion for Q3 2025, versus $1.8 billion for Q2 2025 and $1.8 billion for Q1 2025.